News
Adamis Pharmaceuticals Submits Fast Track Application to FDA for Tempol for the Treatment and Prevention of COVID-19
Adamis Pharmaceuticals Corporation announced the submission of a Fast Track Application to the U.S. Food and Drug Administration (FDA) for Tempol for the treatment and prevention of COVID-19. Tempol is currently being studied in a Phase 2/3 clinical trial...
News
Malvern Panalytical expands pharmaceutical drug development solutions through acquisition of Creoptix
Malvern Panalytical, a company providing advanced analysis and services solutions for the pharma drug product development, as well as services and solutions for other industries, has today announced its acquisition of Creoptix AG, a specialist bioanalysis sensor company. The...
News
Pharmaron acquires commercial API manufacturing facility in the United Kingdom from Recipharm
Pharmaron Beijing Co., Limited announced today that it has acquired Aesica Pharmaceuticals Limited from Recipharm group.
The Cramlington Site in Newcastle, United Kingdom, has an established history of cGMP manufacturing services for an array of Active Pharmaceutical Ingredients (API), ranging...
News
Cyprus Professor Finds Fusion of Delta And Omicron Variant
As per the Bloomberg News report on Saturday, January 8, Leondios Kostrikis, who is a professor in biological sciences at the University of Cyprus, the country has a new strain of COVID-19 which is a fusion of delta and...
News
Merck Doubles Its Pledge To Tackle Maternal Mortality Crisis
A startling figure indeed when we say that around the globe, a lady dies every 2 minutes, due to complications arising from childbirth and pregnancy. However, the fact remains that most of the situations are preventable, and to be...
News
CSafe Global Launches Real-Time Shipment Visibility for Passive Portfolios
CSafe Global, the innovation leader in temperature-controlled solutions for the pharmaceutical industry, announced today it has expanded its real-time shipment visibility platform and technology to the company’s VIP Parcel and Cell & Gene portfolios.
Customers who choose to include a...
IT & Data Management
Autism Clinical Trials Now Open On The TrialWire Platform
TrialWire(TM) is pleased to announce new Autism (ASD) clinical studies are now available on the TrialWire Platform. More than 6 million people have used TrialWire over the past few years to find clinical trials that are right for them...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read